BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 24011630)

  • 21. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.
    Sutherland JS; de Jong BC; Jeffries DJ; Adetifa IM; Ota MO
    PLoS One; 2010 Aug; 5(8):e12365. PubMed ID: 20811496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis - The most suitable surrogate biomarker for latent TB infection.
    Prabhavathi M; Pathakumari B; Raja A
    J Infect; 2015 Aug; 71(2):238-49. PubMed ID: 25936741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection by flow cytometry of ESAT-6- and PPD-specific circulating CD4+ T lymphocytes as a diagnostic tool for tuberculosis.
    Cosmi L; Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Mazzetti M; Vultaggio A; Matucci A; Maggi E; Romagnani S; Annunziato F
    Int Arch Allergy Immunol; 2007; 143(1):1-9. PubMed ID: 17191004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of IFN-gamma and IgG to ESAT-6 and 38 kDa recombinant proteins and their peptides from Mycobacterium tuberculosis in tuberculosis patients and asymptomatic household contacts may indicate possible early-stage infection in the latter.
    López-Vidal Y; de León-Rosales SP; Castañón-Arreola M; Rangel-Frausto MS; Meléndez-Herrada E; Sada-Díaz E
    Arch Med Res; 2004; 35(4):308-17. PubMed ID: 15325505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of T cell response to novel Mycobacterium tuberculosis synthetic overlapping peptides mixtures (Rv2659 and Rv2660) and ESAT-6 in Egyptian patients.
    Salman AM; Rosenkrands I; Andersen P; Abdel-Ghaffar AR
    Egypt J Immunol; 2014; 21(2):75-83. PubMed ID: 25812354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
    Nemes E; Abrahams D; Scriba TJ; Ratangee F; Keyser A; Makhethe L; Erasmus M; Mabwe S; Bilek N; Rozot V; Geldenhuys H; Hatherill M; Lempicki MD; Holm LL; Bogardus L; Ginsberg AM; Blauenfeldt T; Smith B; Ellis RD; Loxton AG; Walzl G; Andersen P; Ruhwald M
    Clin Infect Dis; 2019 Oct; 69(10):1724-1730. PubMed ID: 30668657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis.
    Vincenti D; Carrara S; De Mori P; Pucillo LP; Petrosillo N; Palmieri F; Armignacco O; Ippolito G; Girardi E; Amicosante M; Goletti D
    Mol Med; 2003; 9(3-4):105-11. PubMed ID: 12865946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting.
    Abebe F; Belay M; Legesse M; Mihret A; Franken KS
    Clin Exp Immunol; 2017 Aug; 189(2):241-249. PubMed ID: 28374535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens.
    Chee CB; KhinMar KW; Gan SH; Barkham TM; Pushparani M; Wang YT
    Am J Respir Crit Care Med; 2007 Feb; 175(3):282-7. PubMed ID: 17082492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test.
    Silva BC; Grassi MF; Coutinho R; Mascarenhas RE; Olavarria VN; Coutinho-Borgo A; Kalil J; Cunha Neto E; Fonseca SG
    Mem Inst Oswaldo Cruz; 2014 Dec; 109(8):999-1004. PubMed ID: 25494469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.
    Kobashi Y; Shimizu H; Ohue Y; Mouri K; Obase Y; Miyashita N; Oka M
    Lung; 2010 Aug; 188(4):283-7. PubMed ID: 20422203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study.
    Gourgouillon N; de Lauzanne A; Cottart CH; Curis E; Debord C; Guérin-El Khourouj V; Pédron B; Faye A; Sterkers G
    Pediatr Res; 2012 Oct; 72(4):370-4. PubMed ID: 22797138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
    Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
    Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.
    Kim SY; Park MS; Kim YS; Kim SK; Chang J; Lee HJ; Cho SN; Kang YA
    Scand J Immunol; 2012 Dec; 76(6):580-6. PubMed ID: 22946827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.